Drugs@FDA document
NAGLAZYME Label · BLA 125117 SUPPL-132
Drugs@FDA document · BIOMARIN · Sep 16, 2024
Key facts
| Drug name | NAGLAZYME |
|---|---|
| Document type | Label |
| Application | BLA125117 |
| Submission | SUPPL-132 |
| Company | BIOMARIN |
| Document date | Sep 16, 2024 |
| FDA document | accessdata.fda.gov |
At a glance
- Labeling-Package Insert Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: